13 DE
14 EN

We Care. Research for your Health.

1 Merz Worldwide
- 1.1 Austria
- 1.2 Switzerland
- 1.3 Russia
- 1.4 USA
- 1.5 UK
- 1.6 Mexiko
2 Company
- 2 Company
- 2.1 Philosophy
- 2.2 Facts and Figures
- 2.3 Management Board
- 2.4 History
- 2.5 Merz Pharmaceuticals
- 2.6 Merz Consumer Care
- 2.7 Merz Dental
- 2.8 Merz Hygiene
- 2.9 Merz Group
- 2.10 Locations
3 Research & Development
- 3 Research & Development
4 Professionals
- 4 Professionals
5 Health
- 5 Health
- 5.1.1 Alzheimer’s
- 5.1.2 Depression
- 5.1.3 Dystonia
- 5.4.4 Cold Remedies
- 5.2.1 Hair loss
- 5.3.1 Liver Disease
- 5.3.2 Scars
- 5.1.4 Parkinson’s
- 5.4.11 Vitamins & Minerals
- 5 more
6 Beauty & Wellness
- 6 Beauty & Wellness
- 6.1 Baths
- 6.2 Beauty from Within
- 6.3 Shower Products
- 6.4 Skin Care
- 6.5 Skin, Hair and Nails
- 6.6 Wrinkles
7 Press
- 7 Press
- 7.1 Press Releases
- 7.2 Photos & Logos
8 Career
- 8 Career
- 8.1 Merz as Employer
- 8.2 Job Opportunities
- 8.3 Directions
- 8.4 Contact
9
- 9 Contact

7 Press
- 7.1 Press Releases
  - 7.1.1 Company
    - 7.1.1.1 2000
    - 7.1.1.2 2001
    - 7.1.1.3 2002
    - 7.1.1.4 2003
    - 7.1.1.5 2004
    - 7.1.1.6 2005
    - 7.1.1.7 2006
    - 7.1.1.8 2007
    - 7.1.1.9 2008
  - 7.1.2 Health
- 7.2 Photos & Logos

Merz Pharmaceuticals Taps the Third Largest Pharmaceutical Market in Europe with Merz Italia

Frankfurt am Main, 20.10.2005

Merz Pharmaceuticals is actively continuing its expansion and internationalization strategy with the founding of the subsidiary Merz Italia. The company is headquartered in Milan and is focused on tapping the Italian market – the third largest in Europe and the sixth largest worldwide – with its own marketing and distribution structure and an initial portfolio of selected dermatology products.

The start-up of operations under the management of Dr. Paolo Zambonardi will at first concentrate on products in the field of non-invasive aesthetic dermatology that are already licensed. In the growing Italian market, Merz Pharmaceuticals is seeking to achieve a sales volume of about one third of the total market this year with its hyaluronic acid filler Belotero.

By 2007, the company plans to obtain licensing for additional products from the fields of dermatology and neurology/psychiatry. Merz Pharmaceuticals is already represented in the Italian market through a licensing and distribution partnership with the Danish company H. Lundbeck A/S for the Alzheimer’s drug memantine.

The founding of Merz Italia complements existing subsidiaries and investment companies of Merz Pharmaceuticals in Austria, Switzerland, the USA, Mexico, Uruguay, and Russia. By 2010, additional subsidiaries specializing in dermatology and neurology will follow in France, the UK, and Spain.

Merz Pharmaceuticals (www.merz.com):

Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Merz is a leader in the field of Alzheimer research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology.

Contact:
Merz Pharma GmbH & Co. KGaA
Corporate Communications
Nicole Giesler
Phone.: 069 / 15 03 - 411
Fax: 069 / 15 03 - 400

E-Mail: nicole.giesler@merz.de

Privacy Policy |
Terms of Use |
Imprint
to top

Last update: 14 Mai 2007, 04:26

produced by GPM mbH

0.1 A-
0.2 A
0.3 A+
0.4 Print

We Care. Research for your Health.

Merz Pharmaceuticals Taps the Third Largest Pharmaceutical Market in Europe with Merz Italia

Merz Pharmaceuticals (www.merz.com):

Search

Login for Professionals

German Websites

http://www.merz.com